Principal Financial Group Inc. Raises Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Principal Financial Group Inc. grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 94.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 534,279 shares of the medical instruments supplier’s stock after purchasing an additional 259,589 shares during the quarter. Principal Financial Group Inc.’s holdings in DENTSPLY SIRONA were worth $29,807,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. NuWave Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 172.8% in the 4th quarter. NuWave Investment Management LLC now owns 502 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 318 shares during the period. Dark Forest Capital Management LP purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $50,000. National Bank of Canada FI purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at $55,000. First Horizon Advisors Inc. raised its stake in shares of DENTSPLY SIRONA by 516.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,541 shares of the medical instruments supplier’s stock valued at $118,000 after acquiring an additional 1,291 shares during the period. Finally, Signaturefd LLC raised its stake in shares of DENTSPLY SIRONA by 13.0% in the 4th quarter. Signaturefd LLC now owns 1,786 shares of the medical instruments supplier’s stock valued at $100,000 after acquiring an additional 205 shares during the period. 94.79% of the stock is currently owned by institutional investors and hedge funds.

Shares of XRAY stock opened at $38.23 on Friday. The firm has a market cap of $8.24 billion, a P/E ratio of 22.62, a P/E/G ratio of 2.37 and a beta of 0.94. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 1.12. DENTSPLY SIRONA Inc. has a 1-year low of $35.00 and a 1-year high of $69.07. The firm has a fifty day moving average of $45.95 and a two-hundred day moving average of $51.34.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last announced its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing the consensus estimate of $0.56 by ($0.04). DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The company had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. During the same period in the prior year, the business earned $0.72 earnings per share. DENTSPLY SIRONA’s revenue was up 841.1% on a year-over-year basis. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 2.43 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, April 8th. Stockholders of record on Friday, March 25th were given a $0.125 dividend. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date was Thursday, March 24th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 29.59%.

In other news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction dated Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total value of $273,999.00. Following the transaction, the director now directly owns 35,155 shares in the company, valued at approximately $1,396,005.05. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.69% of the company’s stock.

XRAY has been the subject of a number of recent analyst reports. Robert W. Baird lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and lowered their price target for the company from $67.00 to $48.00 in a report on Tuesday, April 19th. William Blair lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 19th. Bank of America lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and lowered their price target for the company from $66.00 to $49.00 in a report on Tuesday, April 19th. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, April 20th. Finally, HC Wainwright lowered their price target on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating for the company in a report on Friday, April 22nd. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $52.89.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.